Literature DB >> 27131613

Usefulness of the Myocardial Infarction and Cardiac Arrest Calculator as a Discriminator of Adverse Cardiac Events After Elective Hip and Knee Surgery.

Brandon Peterson1, Mehrdad Ghahramani2, Stephanie Harris2, Kristen Suchniak-Mussari2, Gurneet Bedi2, Charles Bulathsinghala2, Andrew Foy2.   

Abstract

The 2014 American College of Cardiology and American Heart Association guidelines on perioperative evaluation recommend differentiating patients at low risk (<1%) versus elevated risk (≥1%) for cardiac complications to guide appropriate preoperative testing. Among the tools recommended for estimating perioperative risk is the National Surgical Quality Improvement Program (NSQIP) Myocardial Infarction and Cardiac Arrest (MICA) risk calculator. We investigated whether the NSQIP MICA risk calculator would accurately discriminate adverse cardiac events in a cohort of adult patients undergoing elective orthopedic surgery. We retrospectively reviewed 1,098 consecutive, elective orthopedic surgeries performed at Hershey Medical Center from January 1, 2013, to December 31, 2014. Adverse cardiac events were defined as myocardial infarction or cardiac arrest within 30 days of surgery. The mean estimated risk for adverse cardiac events using the NSQIP MICA risk calculator was 0.54%, which was not significantly different (p = 1) compared with the observed incidence of 0.64% (7 of 1,098 procedures). The c-statistic for discriminating adverse cardiac events was 0.85 (95% CI 0.67 to 1) for the NSQIP MICA risk calculator and 0.9 (95% CI 0.75 to 1) for the Revised Cardiac Risk Index. In conclusion, the NSQIP MICA risk calculator is a good discriminator of adverse cardiac events in patients undergoing elective hip and knee surgery, performing comparably to the Revised Cardiac Risk Index.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27131613     DOI: 10.1016/j.amjcard.2016.03.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1. 

Authors:  Berrin Günaydın; Ömer Kurtipek
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-06-01

Review 2.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

3.  Incidence of Myocardial Infarction After High-Risk Vascular Operations in Adults.

Authors:  Yen-Yi Juo; Aditya Mantha; Ramin Ebrahimi; Boback Ziaeian; Peyman Benharash
Journal:  JAMA Surg       Date:  2017-11-15       Impact factor: 14.766

4.  Characteristics and long-term mortality of patients with ST-elevation or non-ST-elevation myocardial infarction after orthopaedic surgery.

Authors:  Wenlan Hu; Kaiping Zhao; Youzhou Chen; Jihong Wang; Mei Zheng; Ying Zhao; Qiong Zhao; Xingshan Zhao
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Predicting complications of major head and neck oncological surgery: an evaluation of the ACS NSQIP surgical risk calculator.

Authors:  Peter S Vosler; Mario Orsini; Danny J Enepekides; Kevin M Higgins
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-03-22

6.  Risk factors associated with cardiac complication after total joint arthroplasty of the hip and knee: a systematic review.

Authors:  Yassin Elsiwy; Ivana Jovanovic; Kenji Doma; Kaushik Hazratwala; Hayley Letson
Journal:  J Orthop Surg Res       Date:  2019-01-11       Impact factor: 2.359

7.  Pre-operative clinical predictors for cardiology referral prior to total joint arthroplasty: the 'asymptomatic' patient.

Authors:  Yassin Elsiwy; Tristan Symonds; Kenji Doma; Kaushik Hazratwala; Matthew Wilkinson; Hayley Letson
Journal:  J Orthop Surg Res       Date:  2020-11-10       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.